The Wolf Within: What You Need to Know About Lupus
From Immune System Malfunction to Modern Treatment
When I (Aimee) think about lupus, I don’t just think about the science - I think about one of my former students. She was diagnosed with lupus during college, and the disease quickly became a relentless adversary. The usual first-line medication, steroids, that dampen the immune response and often bring relief, barely made a dent. Her lupus was refractory, stubbornly resisting every standard approach.
Eventually, her doctors turned to an advanced therapy - a type of immunotherapy that depleted her B cells, the immune cells that play a central role in lupus. At the time, its use was off-label and an unconventional last-ditch measure, but it worked. Slowly, her symptoms eased, and she regained control of her life.
What amazes me most is not just the science behind her recovery, but her resilience. Despite years of debilitating illness, she persevered, graduated, and went on to earn her PharmD. She is brilliant, kind, and cheerful - a living testament to the power of perseverance and modern medicine, particularly immunotherapy or treatments that harness the body’s own immune system to fight disease.
Her story is just one example of how complex lupus can be and why understanding this disease - from the molecular, cellular, and immunological level - matters.
So, what exactly is lupus, and why does it sometimes require such aggressive treatments? Let’s discuss…
What Is Lupus?
Systemic Lupus Erythematosus (SLE), commonly known as lupus, is a chronic autoimmune disease that affects millions worldwide. For patients with lupus, the immune system mistakenly attacks healthy tissues. This can lead to inflammation and damage in multiple organs, including the skin (most notably a distinctive rash across the face), joints, kidneys, reproductive system, intestines, lungs, and even the heart. Even the name hints at its bite: lupus is Latin for wolf, named centuries ago for the facial rashes that physicians thought resembled wolf bites.
SLE is the most common and severe form of lupus, but several other types exist, including Cutaneous lupus erythematosus (CLE), Drug-induced lupus (DIL), and Neonatal lupus syndrome (NLS).
Because lupus symptoms can mimic other conditions, it’s often misunderstood.
When the Immune System Turns on Itself
Approximately 23.2 per 100,000 people in North America have lupus. It’s a complex autoimmune disease with multifactorial causes, arising from an interplay of genetic predisposition, environmental triggers, hormonal influences, and immune system dysregulation. These factors collectively contribute to the loss of immune tolerance and chronic inflammation characteristic of the disease.
Genetics: A family history of autoimmune diseases increases risk. No single genetic cause has been identified, although changes in many classes of genes involved in the immune system have shown an association with lupus.
Environmental triggers: Infections, ultraviolet (UV) light exposure, and certain medications can spark disease activity in individuals with a predisposition to the disease.
Hormonal influences: Lupus is far more common in women of childbearing age (ages 15 - 44), suggesting estrogen and other hormones may play a role.
At its core, lupus, like all autoimmune diseases, is a case of mistaken identity. The immune system acts like a home security system that provides protection, but in the case of autoimmune diseases, like lupus, the immune security system malfunctions, attacking its own house and causing widespread damage.
In autoimmune diseases, the immune system loses its ability to distinguish between foreign invaders and the body’s own cells and tissues. In lupus, this loss of ‘self-tolerance’ leads to the production of autoantibodies that target healthy cells and tissues. These autoantibodies form immune complexes (clusters of antibodies bound to their target antigen) that deposit in organs, triggering inflammation and tissue damage.
What Lupus Looks (and Feels) Like
Like many autoimmune diseases, lupus has symptoms that can vary widely and often come in cycles called ‘flares’ and ‘remissions.’
Some of the most common signs include:
Fatigue: The most frequent complaint among patients.
Joint pain and swelling: Often in the hands, wrists, and knees.
Skin changes: A hallmark sign is the butterfly-shaped rash across the cheeks and nose. Many patients also experience sensitivity to sunlight.
Other symptoms: Headaches, hair loss, mouth sores, low fevers, swollen lymph nodes, blood clots, chest pain when breathing deeply, and fingers turning blue or white in cold temperatures (Raynaud’s phenomenon).
Because these symptoms overlap with other conditions, lupus can be challenging to diagnose.
Piecing Together a Diagnosis
Diagnosing lupus is notoriously challenging because the disease is highly variable and can affect nearly every organ system. Symptoms range from mild skin rashes to severe kidney or neurological involvement, and no single test can confirm lupus. Instead, diagnosis relies on a combination of clinical signs—such as joint pain, chest discomfort, or characteristic rashes—and laboratory findings like autoantibodies and altered complement levels.
In fact, many autoimmune diseases share overlapping symptoms such as fatigue, joint pain, and rashes, which makes diagnosis challenging. In lupus, the process often requires a wide range of medical evaluations and careful integration of symptoms and test results. It’s rarely the work of a single physician. Instead, diagnosing and managing lupus typically involves a team of specialists:
Rheumatologists, who lead care for autoimmune and connective tissue diseases
Nephrologists, when lupus affects the kidneys (lupus nephritis)
Dermatologists, for skin manifestations like rashes and lesions
Hematologists, to address blood-related complications
Cardiologists and pulmonologists, when the heart or lungs are involved
Neurologists, for nervous system symptoms
This collaborative approach reflects the complexity of lupus, which can affect nearly every organ system. Understanding the disease at its molecular and immunological roots isn’t just about science; it’s about giving these specialists better tools and therapies, so patients receive more precise, effective care.
For decades, physicians have used classification criteria developed by the American College of Rheumatology (ACR), which list features such as oral ulcers, arthritis, kidney disorders, and positive ANA tests. These criteria were updated in 2019 by the EULAR/ACR system to improve sensitivity and to include new markers, such as low complement levels and autoimmune hemolysis. Even so, lupus remains a moving target as its symptoms often accumulate over time, and some manifestations fall outside these criteria. Researchers are now exploring molecular markers and precision medicine approaches to enable earlier, more accurate diagnosis, which are critical steps toward tailoring treatment for this complex disease.
For lupus, the evaluation involves a combination of blood and urine tests, and a clinical evaluation.
Blood Tests to assess the quantity of cell types and proteins in the blood that are hallmark signs of disease:
ANA (Antinuclear Antibody) – a non-specific screening test and the traditional entry criterion for lupus
Specific autoantibodies – anti-dsDNA, anti-Sm, antiphospholipid antibodies
Complement Levels – low C3 and/or C4
Complete Blood Cell counts (CBC) – hemolytic anemia, leukopenia, and thrombocytopenia
Erythrocyte Sedimentation Rate (ESR) - detects inflammatory activity in the blood
Urine Tests to evaluate the amount of blood or protein in the urine:
Urinalysis – proteinuria (>0.5 g/day), cellular casts
Kidney Biopsy – confirms lupus nephritis when suspected
Clinical Evaluation to assess symptoms and organ involvement. Diagnosis often takes time because lupus can mimic other illnesses:
Skin & oral exam – rashes, ulcers, non-scarring alopecia
Joint assessment – non-erosive arthritis
Cardiac & lung imaging – echocardiogram or chest imaging for pleuritis/pericarditis
Neurological assessment – seizures or psychosis unexplained by other causes
Treatment Options
While there’s no cure for lupus, treatments aim to control symptoms, prevent flares, and protect organs. Common approaches include medications to dampen the immune response and thereby decrease inflammation:
Antimalarial drugs: Hydroxychloroquine (Plaquenil) is often the first-line treatment for most patients. It works through a different mechanism than malaria treatment, decreasing the immune response that causes inflammation and tissue damage. This medicine works through alteration to lysosomal pH, which impacts immune cell function and antigen processing - but there are several additional proposed mechanisms to its function as an anti-rheumatic drug.
Corticosteroids: Used to reduce inflammation during flares quickly. These are also medications that can suppress the immune system. Medications commonly used include prednisone and methylprednisone. These medications make a complex with cellular proteins that go to the nucleus and suppress the expression of inflammatory genes.
Immunosuppressants: Medications such as Azathioprine, Mycophenolate, Methotrexate, Cyclophosphamide, and Voclosporin are used in severe cases. These medications have several mechanisms, including preventing the multiplication of and blocking the activation of immune cells.
Biologics: Targeted antibody therapies such as belimumab or anifrolumab can block specific immune pathways, thereby reducing immune responses and inflammation. Some others can be used off-label in some cases (Rituximab, Obinutuzumab). Most of these biologics block B-cell activity or deplete B cells.
Immunotherapeutics: Among the most promising immunotherapeutic approaches under investigation are chimeric antigen receptor (CAR) T-cells, which are T cells from the patient’s own body molecularly engineered to target a specific molecule such as a marker found on B cells, the immune cell that produces antibody. CAR T-cell therapy is emerging as a formidable approach to the treatment of a variety of autoimmune diseases, including lupus.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): For mild symptoms, help to reduce inflammation and control pain (examples include ibuprofen, naproxen, meloxicam). Most of these medications inhibit the activity of COX enzymes involved in inflammation.
Organ-specific treatments: antihypertensives, anticoagulants, antibiotics, supplements.
These medications are administered through different routes depending on whether they are small molecules or biologics. Small-molecule drugs are typically simple chemicals, like aspirin or ibuprofen. They are optimized to have good cellular permeability, allowing them to reach target tissues via intestinal absorption when taken orally. Biologics are much larger molecules, like antibodies or proteins. Due to their large size and complex structure, they cannot pass through cell membranes and thus need to be given by injection or infusion to reach the target tissue. These routes depend on the size of the molecule and its bioavailability, not on how “strong” the treatment is.
Treatment plans are highly personalized, depending on which organs are affected, the severity of symptoms, each person’s medical history, other medications, and lifestyle.
In combination with treatments to modulate the immune system and manage symptoms, a healthy lifestyle can also support patients with lupus, including a balanced diet and regular exercise.
Final Thoughts
Lupus, like most autoimmune conditions, is not a single pathway gone awry; it’s a tangled web of immune miscommunication, genetic predisposition, and environmental triggers. Every flare, every symptom, reflects a cascade of processes we are only beginning to unravel. In medicine, understanding these root causes is known as studying a disease’s pathogenesis (how it develops and progresses) and pathophysiology (the changes that occur in the body as a result). The more we learn about these mechanisms, the better equipped we are to move beyond symptom management and design therapies that target the source.
For the millions diagnosed worldwide, deeper knowledge isn’t just academic—it’s the key to living healthier, longer lives.
Lupus is complex, but understanding its causes, symptoms, and treatment options can empower patients and families. If you or someone you know experiences persistent fatigue, joint pain, or unexplained rashes, consult a healthcare professional. Early diagnosis and treatment make a big difference.
Stay Curious,
Unbiased Science
Resources
If you or someone you care about has been diagnosed with lupus—or you’re looking to learn more—here are some trusted places to start.
For support:
To learn more:
 | A guest post by
|
 | A guest post by
|
My first "patient" at start of medical school (late 1980s) was a ~18 year old with SLE diagnosed several years prior - part of a course titled something like "The BioPsychosocial Model."
We met weekly through my Year-1 to talk. Initially, I wrote up medical style History and Physical (less most of the physical), then weekly "Progress Notes." Then end of semester and end of year papers. She was hospitalized more often than not. She was to remain," my patient," until graduation, meeting regularly, but less frequently because of my conflicting commitments. We didn't make it through my final year - out of area SNF placement.
Already with advanced renal insufficiency, soon ESRD, then initiation if hemodialysis and then peritoneal dialysis with repeated episodes of SBE and cellulitis - cutaneous involvement, and musculoskeletal, eventually ocular and neurologic and .... other textbook complications.
I hadn't thought about Pat in years, but what a shitty, unfair disease. Therapeutics are much better by now, of course, but hardly good enough.
Really strong explanation of immune tolerance breakdown here. The point about B-cell depletion being "off-label and unconventional" in the past but now gaining traction shows how treatment paradigms shift when we understand the underlying mechanisms better. I remember reading about early CAR-T trials for SLE where complete remission seemed almost unbelieveable given how intractable some cases are. The security system analogy is spot on too becuase it captures how autoimmunity isn't just overactivity but misdirected specificity.